Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Inhibition of HRP-3 using modified oligonucleotides
Anthranilic diamide compositions for propagle coating
Systems, methods, and apparatus to prepare a mobile device for provisioning
Methods and apparatus to perform time zone determination by a mobile station
Communication system, authentication device, control server, communication method, and program
Case for camera
Treatment of diabetes with milk protein hydrolysate
  Randomly Featured Patents
Container security system
Method of mounting a retaining ring on an electric starter shaft comprising a starter drive assembly and corresponding starter
Air dryer module
Flame surveying means in burner ignition
Candle assembly including a windowsill stabilizer
Seal structure for engine
Nail polish applicator
Method and apparatus for controlling pixel sensor elements
Anoxic biotreatment cell
Circuit arrangement for generating synchronization signals in a transmission of data